What is NDC 51655-311?

51655-311 is the product NDC for Lisinopril and Hydrochlorothiazide, Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1 tablet, listed with the FDA by Northwind Health Company, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What is the active ingredient?

Hydrochlorothiazide, Lisinopril.

Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lisinopril and Hydrochlorothiazide?

86 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lisinopril and Hydrochlorothiazide NDC 51655-311

NDC codes

FDA NDC Directory

Product NDC (as listed)51655-311Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51655-0311Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51655-311-26	51655031126	90 TABLET in 1 BOTTLE, PLASTIC (51655-311-26)Marketed from Sep 14, 2022
51655-311-52	51655031152	30 TABLET in 1 BOTTLE, PLASTIC (51655-311-52)Marketed from Jul 14, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisinopril and Hydrochlorothiazide
Generic name (nonproprietary): lisinopril and hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 12.5 mg/1Lisinopril — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Northwind Health Company, LLCNDC labeler code 51655
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077912
Marketing start: Jul 14, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 51655-311_49d8fdcc-d10d-77cb-e063-6394a90ab6b3SPL ID 49d8fdcc-d10d-77cb-e063-6394a90ab6b3SPL set ID f2b94985-c79d-40e3-e053-2a95a90a0d78RxCUI 197886UNII 0J48LPH2TH, E7199S1YWR
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655031126 followed by a unit qualifier and the quantity

Package 51655-0311-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lisinopril and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51655-311

What is NDC 51655-311?: 51655-311 is the product NDC for Lisinopril and Hydrochlorothiazide, Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1 tablet, listed with the FDA by Northwind Health Company, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lisinopril and Hydrochlorothiazide.
What is the active ingredient?: Hydrochlorothiazide, Lisinopril.
Who is the labeler?: Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lisinopril and Hydrochlorothiazide?: 86 other product NDCs are listed under this name. See all Lisinopril and Hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lisinopril and Hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Coupler LLC	67046-0433	67046-0433-03
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4516	70518-4516-0070518-4516-01
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	GSMS, Incorporated	51407-564	51407-0564-0551407-0564-90
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	GSMS, Incorporated	51407-565	51407-0565-0551407-0565-90
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	GSMS, Incorporated	51407-566	51407-0566-0551407-0566-90
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-586	60760-0586-90
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0207	80425-0207-03
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8253	68788-8253-0168788-8253-0368788-8253-06+1 more
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8224	68788-8224-0168788-8224-0368788-8224-06+1 more
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-3505	70518-3505-0070518-3505-0170518-3505-04

All 87 Lisinopril and Hydrochlorothiazide NDCs

Other NDCs under ANDA 077912

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077912
Product	Strength	Form · route	Labeler	Product NDC
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	A-S Medication Solutions	50090-2974
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Northwind Health Company, LLC	51655-412
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-0382
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	Northwind Health Company, LLC	51655-413
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	A-S Medication Solutions	50090-6976
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-1945
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Lupin Pharmaceuticals, Inc.	68180-518
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Lupin Pharmaceuticals, Inc.	68180-519
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	Lupin Pharmaceuticals, Inc.	68180-520
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Proficient Rx LP	71205-022
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2183
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	Bryant Ranch Prepack	63629-3739
Lisinopril And Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Proficient Rx LP	63187-319
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3177
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-556
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Coupler LLC	67046-0433
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-557
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-558
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-838
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Bryant Ranch Prepack	63629-4470

Showing 20 of 34.